rs759838082
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_ModerateBP6_Very_Strong
The ENST00000270162.8(SIK1):c.1064G>A(p.Arg355His) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R355C) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000270162.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIK1 | NM_173354.5 | c.1064G>A | p.Arg355His | missense_variant | 9/14 | ENST00000270162.8 | NP_775490.2 | |
SIK1 | XM_011529474.3 | c.972+320G>A | intron_variant | XP_011527776.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIK1 | ENST00000270162.8 | c.1064G>A | p.Arg355His | missense_variant | 9/14 | 1 | NM_173354.5 | ENSP00000270162 | P1 | |
SIK1 | ENST00000644871.1 | n.9G>A | non_coding_transcript_exon_variant | 1/2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 3464Hom.: 0 Cov.: 0 FAILED QC
GnomAD3 exomes AF: 0.000218 AC: 49AN: 225070Hom.: 0 AF XY: 0.000245 AC XY: 30AN XY: 122276
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000924 AC: 4AN: 43274Hom.: 1 Cov.: 0 AF XY: 0.0000438 AC XY: 1AN XY: 22846
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 3464Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 1528
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 15, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | SIK1: BS1, BS2 - |
Developmental and epileptic encephalopathy, 30 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at